Skip to main content
. Author manuscript; available in PMC: 2021 May 14.
Published in final edited form as: Pediatr Exerc Sci. 2020 Apr 25;32(3):124–131. doi: 10.1123/pes.2019-0192

Table 3.

Pearson Correlations (95% CI) Between Cardiorespiratory Fitness and Body Composition and Cardiometabolic Health Markers

VO2peak (mL/kg FFM/min)
VO2peak (mL/kg BW/min)
Delta efficiency (%)
Measure n = 20 n = 20 n = 29
Fat mass index −.24 (−.57 to .15) −.55* (−.80 to −.14) .30 (−.08 to .60)
%BF −.24 (−.57 to .15) −.60** (−.82 to −.21) .40* (.04 to .67)
VATa −.10 (−.52 to .36) −.16 (−.56 to .30) .16 (−.22 to .50)
SATa −.49* (−.77 to −.06) −.68** (−.86 to −.34) .11 (−.27 to .46)
Systolic BP (mm Hg) −.06 (−.49 to .39) −.03 (−.47 to .42) −.09 (−.44 to .29)
Diastolic BP (mm Hg) −.42 (−.73 to .03) −.52* (−.78 to −.10) −.03 (−.39 to .34)
HOMA-IR .12 (−.34 to .53) .02 (−.43 to .46) −.11 (−.46 to .27)
LDL-C (mg/dL) −.08 (−.51 to .38) −.04 (−.47 to .41) −.04 (−.40 to .33)
HDL-C (mg/dL) −.08 (−.51 to .38) −.18 (−.58 to .29) .17 (−.21 to .51)
TRIG (mg/dL) −.03 (−.47 to .42) −.07 (−.50 to .38) −.07 (−.43 to .30)
hsCRP (mg/L) .01 (−.43 to .45) −.23 (−.61 to .24) .39* (.03 to .66)
Cardiometabolic risk score −.09 (−.51 to .37) −.16 (−.56 to .30) −.03 (−.39 to .34)

Abbreviations: BP, blood pressure; BW, body weight; CI, confidence interval; FFM, fat-free mass; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment of insulin resistance; hsCRP, high-sensitivity C-reactive protein; LDL-C, low-density lipoprotein cholesterol; SAT, subcutaneous adipose tissue; TRIG, triglycerides; VAT, visceral adipose tissue; VO2peak, peak aerobic capacity; %BF, percentage body fat.

Note: Bolded values reached statistical significance, at a level further defined by ** or *

**

P < .01

*

P < .05.

a

n = 18/27 due to poor quality MRI data in 2 participants.